Management of Pituitary Adenoma with Isolated Elevated FSH

Diagnosis and Evaluation

The Endocrine Society recommends confirming elevated FSH with repeat testing and evaluating for other pituitary hormone abnormalities, including complete anterior pituitary hormone assessment (TSH, ACTH, GH, prolactin, LH) 3
MRI of the pituitary with contrast is used to characterize the adenoma, and gonadotroph adenoma is the most common cause of isolated FSH elevation with adenoma 1, 2
TSH-secreting adenoma with co-secretion of FSH and non-functioning pituitary adenoma with disruption of normal feedback mechanisms are other possible causes of isolated FSH elevation 1, 2

Transsphenoidal surgery by an experienced pituitary surgeon (minimum 50 operations/year per surgical unit) is the first-line treatment for patients with isolated elevated FSH associated with pituitary adenoma 1
The American College of Surgeons recommends an endoscopic approach, which may be superior for preserving pituitary function compared to microscopic approach 1
Histopathological assessment should include immunostaining for pituitary hormones and Ki-67 1

Monitor fluid and electrolyte balance strictly in the perioperative period, and assess for surgical cure with repeat FSH levels 4-6 weeks post-surgery 1
If residual disease is present, consider medical therapy with GnRH analogs or somatostatin analogs, and radiation therapy for residual tumor growth not controlled by surgery and medical therapy 1, 2

Regular FSH measurements to assess treatment efficacy, and MRI surveillance: 3 months post-surgery, then annually for 3-5 years if stable 2
Regular assessment of other pituitary functions to monitor for development of hypopituitarism 2

Offer genetic assessment to all patients with pituitary adenoma, and consider testing for MEN1 mutations, AIP mutations, and familial isolated pituitary adenoma syndromes 1

Misinterpreting elevated FSH as primary gonadal failure rather than adenoma-related, and neglecting genetic testing, which could reveal syndromic causes requiring different management approaches 1

In patients with incompletely pneumatized sphenoid sinuses, transsphenoidal surgery is still the technique of choice, and in patients with visual field defects, recovery is unlikely after the first post-operative month 1
Ki-67 index ≥3% combined with local invasion predicts a 25% recurrence rate after surgery 1